JAKKS Pacific has entered a multi-year global master toy license agreement with Skydance Products & Publishing for the upcoming Paramount Pictures live-action film K-Pop: The Debut, set to release in theaters worldwide on February 26, 2027. The partnership will produce a wide range of products including dolls, collectibles, wearables, and novelty items inspired by the film's music and characters, targeting K-Pop fans and collectors. This collaboration aims to capitalize on the global rise of K-Pop fandom and extend engagement beyond the film's debut. JAKKS holds rights through December 31, 2028, with more product details to be announced closer to launch.
Skydance and JAKKS Pacific's global toy license agreement for K-Pop: The Debut provides context for consumer cyclical sector activity on Pluang as of Nov 12, 2026 20:21 WIB. Of 134 priced US stocks in this sector, 52 rose and 70 fell. Notable movers include STLA at USD 3.98 with a 1-day change of -3.16%, QS at USD 4.08 with 89% sell order activity, and VSXY at USD 106.60 with 93% buy order activity, the latter showing the strongest buying interest.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
